STARTSEITE
Current issue
Archives
Impressum
Datenschutz
 
 
  THERAPY FROM A CRITICAL VIEWPOINT
 

Celecoxib (CELEBREX, generics) - as safe as naproxen and ibuprofen regarding cardiovascular events?

Prevention of thromboembolism after knee arthroscopy or lower-leg casting

Rivaroxaban for patients with atrial fibrillation undergoing placement of stents: doubtful benefits compared with warfarin

 
  a-t READER'S QUESTIONS AND COMMENTS

Adjuvanted flu vaccine FLUAD … clinical efficacy benefits still not proven

Carotis plaques detected by screening in healthy people - what should you do?

Restrict package size for colchicine preparations

 
  IN BRIEF
 

USA: warning notice for homoeopathics

Pfizer/UK: 100 million € fine because of high prices

 
  CURRENT ADR NETWORK REPORT
 

Angioedema and other intolerance reactions with oral lavendula oil (LASEA)

 
  SIDE EFFECTS
 

Unusual coloured urine due to drugs

 
  e a-t IN THE INTERNET
 

Hepatitis C: sofosbuvir plus velpatasvir (EPCLUSA)

 

© arznei-telegramm 12/2016